Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed May 11, 2022 · 10-Q · 41 days after period end · 0001520138-22-000201
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$7.04M | -$2.99M | -$366.40K | -$178.50K |
| EPS Diluted | -$0.28 | -$0.22 | -$0.07 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 11, 2022 · 41 d after period end
